Review



human melanoma g361 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human melanoma g361 cells
    Human Melanoma G361 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 468 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/G-361/pm41683370-54-0-4
    Average 96 stars, based on 468 article reviews
    human melanoma g361 cells - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells.
    Article Snippet: Normal human epidermal melanocytes (HEMn-MP; Cascade Biologics, Portland, OR, USA) were maintained in Medium 254 supplemented with Human Melanocyte Growth Supplement, according to the supplier’s instructions. .. Human melanoma G361 cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco’s Modified Eagle Medium (WelGene, Gyeongsan, Republic of Korea) containing 5% fetal bovine serum (Gibco, Gaithersburg, MD, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin. ..

    Article Title: Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells
    Article Snippet: Normal human epidermal melanocytes (HEMn-MP; Cascade Biologics, Portland, OR, USA) were maintained in Medium 254 supplemented with Human Melanocyte Growth Supplement, according to the supplier’s instructions. .. Human melanoma G361 cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco’s Modified Eagle Medium (WelGene, Gyeongsan, Republic of Korea) containing 5% fetal bovine serum (Gibco, Gaithersburg, MD, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin. ..

    Article Title: MicroRNA-218 inhibits melanogenesis by directly suppressing microphthalmia-associated transcription factor expression
    Article Snippet: Cell culture Murine melan-a cells, an immortalized cell line with normal melanocyte characteristics, 26 (kindly provided by Prof DC Bennett, St. George’s Hospital Medical School), were cultured in RPMI 1640 medium supplemented with 5% FBS (Gibco) and 200 nM of 12-O-tetradecanoylphorbol-13-acetate (TPA). .. Human melanoma G361 cells (ATCC) were cultured in McCoy 5A medium supplemented with 10% FBS. .. Human melanoma WM35 cells and WM39 cells (ATCC) were cultured in MCDB: L-15(4:1) medium supplemented with 2% FBS, 5 μg/ml of bovine insulin, and 1.68 mM of CaCl 2 .

    Article Title: Live-cell imaging Unveils stimulus-specific dynamics of Nrf2 activation in UV-exposed melanoma cells: Implications for antioxidant compound screening.
    Article Snippet: .. Human melanoma G361 cells, obtained from the American Type Culture Collection (ATCC, Rockville, MD, US), were cultured in Dulbecco’s Modified Eagle Medium (DMEM) enriched with 10 % fetal bovine serum (FBS) and an antibiotic cocktail of penicillin (100 units/ mL) and streptomycin (100 μg/mL). ..

    Modification:

    Article Title: Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells.
    Article Snippet: Normal human epidermal melanocytes (HEMn-MP; Cascade Biologics, Portland, OR, USA) were maintained in Medium 254 supplemented with Human Melanocyte Growth Supplement, according to the supplier’s instructions. .. Human melanoma G361 cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco’s Modified Eagle Medium (WelGene, Gyeongsan, Republic of Korea) containing 5% fetal bovine serum (Gibco, Gaithersburg, MD, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin. ..

    Article Title: Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells
    Article Snippet: Normal human epidermal melanocytes (HEMn-MP; Cascade Biologics, Portland, OR, USA) were maintained in Medium 254 supplemented with Human Melanocyte Growth Supplement, according to the supplier’s instructions. .. Human melanoma G361 cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco’s Modified Eagle Medium (WelGene, Gyeongsan, Republic of Korea) containing 5% fetal bovine serum (Gibco, Gaithersburg, MD, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin. ..

    Article Title: Live-cell imaging Unveils stimulus-specific dynamics of Nrf2 activation in UV-exposed melanoma cells: Implications for antioxidant compound screening.
    Article Snippet: .. Human melanoma G361 cells, obtained from the American Type Culture Collection (ATCC, Rockville, MD, US), were cultured in Dulbecco’s Modified Eagle Medium (DMEM) enriched with 10 % fetal bovine serum (FBS) and an antibiotic cocktail of penicillin (100 units/ mL) and streptomycin (100 μg/mL). ..



    Similar Products

    96
    ATCC human melanoma g361 cells
    Human Melanoma G361 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/G-361/pm41683370-54-0-4
    Average 96 stars, based on 1 article reviews
    human melanoma g361 cells - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    ATCC human melanoma cells g361
    Human Melanoma Cells G361, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/G-361/pm41373883-260-0-8
    Average 96 stars, based on 1 article reviews
    human melanoma cells g361 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    ATCC g361 melanoma cell line
    G361 Melanoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/G-361%3B+Melanoma%3B+Human/pm40999671-69-14-18
    Average 94 stars, based on 1 article reviews
    g361 melanoma cell line - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    National Centre for Cell Science human melanoma skin cancer cells g361
    Human Melanoma Skin Cancer Cells G361, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/g361++melanoma+/pm39520556-35-0-14
    Average 90 stars, based on 1 article reviews
    human melanoma skin cancer cells g361 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    96
    ATCC human melanoma cell lines g361
    Fig. 2. Apoptotic effects following knockdown of Dock180 and Elmo1 in <t>G361</t> and SK-MEL-2 cells. Cells were treated with Dock180- or Elmo1-specific small interfering RNA (siRNA). (A) The percentage of cell viability was measured by MTT assay as mean±standard devia- tions for three independent experiments. (B) Phase contrast images of G361 and SK-MEL-2 cells. (C) In DAPI staining, both chromatin con- densation and nuclear fragmentation were increased in G361 and SK-MEL-2 cells following treatment of si-Dock180 or si-Elmo1. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.
    Human Melanoma Cell Lines G361, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/G-361/pm38086358-34-1-12
    Average 96 stars, based on 1 article reviews
    human melanoma cell lines g361 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    ATCC human g361 malignant melanoma cells
    Fig. 4 Increase of WIPI1 protein enhances autophagic flux. a Immunoblot analysis of LC3B lipidation in U2OS cells after transfection with control plasmids (9E10) or plasmids encoding 9E10-tagged WIPI1. U2OS cells were transfected with the indicated amounts of plasmids for 48 h before protein extraction and immunoblotting against LC3B, 9E10-tagged WIPI1 or GAPDH, n = 3. Additional immunoblots provided in Supplementary Fig. 5a. b U2OS Cas9 control or U2OS WIPI1 KO cells were transfected with control plasmids (9E10) or plasmids encoding 9E10-tagged WIPI1 for 48 h, followed by treatment with bafilomycin A1 (BafA1) in fed conditions for 3 h. Immunoblotting was conducted against LC3B, 9E10 and tubulin (n = 6, mean ± SD, Two-way ANOVA with Tukey’s multiple comparisons test). WIPI1 deficiency control Taqman qPCR is presented in Supplementary Fig. 6b, and representative Western blots in Supplementary Fig. 6c. c U2OS cells stably expressing GFP-WIPI2 were transfected with control plasmids or plasmids encoding mCherry-tagged WIPI1 for 48 h. The numbers of GFP-WIPI2 puncta cells were assessed by fluorescence microscopy in transfected cells. Welch’s t test, mean ± SD, up to 1272 analysed cells from n = 4 in duplicates. d U2OS Cas9 control or U2-OS WIPI1-KO cells were seeded into 96-well glass bottom plates and transfected with siABL1/2, siDDR1 or nontargeting siRNA (siControl) for 48 h, followed by treatment with either DMEM/FBS (fed) or EBSS (starved) for 3 h. After fixation, cells were stained with DAPI and anti-WIPI2/AF488. By automated confocal LSM, 20 images per well were acquired and between 621 to 2563 single cells (from n = 3) subjected to automated CellProfiler-based image analysis (threshold-based puncta segmentation). For statistical analysis, a two-way ANOVA with Tukey’s multiple comparisons test was performed (mean ± SD). e <t>G361</t> cells were transfected with plasmids encoding GFP or GFP-WIPI1 and were fed or starved for 3 h in the presence or absence of bafilomycin A1, followed by anti-WIPI2/AF546 immunofluorescence staining. Confocal LSM stacks were acquired, and the numbers of WIPI2 puncta-positive cells per acquired image (individual data points represent the result derived from each image) were counted (left panel: two-way ANOVA with Tukey’s post-hoc test, mean ± SD, up to 215 single cells from n = 3 for each condition). Indicative of the presence of overexpressed GFP-WIPI1 are elongated, perinuclear autophagic membranes found to colocalize with WIPI2 (right panel: Scale bar: 5 μm, extended image presentation in Supplementary Fig. 5b). Supplementary material is available (Supplementary Fig. 6d; Supplementary Data 1). P values: *p < 0.05; **p < 0.01; ***p < 0.001; ns not significant.
    Human G361 Malignant Melanoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+melanoma+g361+cells/G-361/pm37620393-275-7-12
    Average 96 stars, based on 1 article reviews
    human g361 malignant melanoma cells - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 2. Apoptotic effects following knockdown of Dock180 and Elmo1 in G361 and SK-MEL-2 cells. Cells were treated with Dock180- or Elmo1-specific small interfering RNA (siRNA). (A) The percentage of cell viability was measured by MTT assay as mean±standard devia- tions for three independent experiments. (B) Phase contrast images of G361 and SK-MEL-2 cells. (C) In DAPI staining, both chromatin con- densation and nuclear fragmentation were increased in G361 and SK-MEL-2 cells following treatment of si-Dock180 or si-Elmo1. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.

    Journal: Annals of dermatology

    Article Title: Overexpression of Dock180 and Elmo1 in Melanoma is Associated with Cell Survival and Migration.

    doi: 10.5021/ad.23.023

    Figure Lengend Snippet: Fig. 2. Apoptotic effects following knockdown of Dock180 and Elmo1 in G361 and SK-MEL-2 cells. Cells were treated with Dock180- or Elmo1-specific small interfering RNA (siRNA). (A) The percentage of cell viability was measured by MTT assay as mean±standard devia- tions for three independent experiments. (B) Phase contrast images of G361 and SK-MEL-2 cells. (C) In DAPI staining, both chromatin con- densation and nuclear fragmentation were increased in G361 and SK-MEL-2 cells following treatment of si-Dock180 or si-Elmo1. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.

    Article Snippet: The human melanoma cell lines G361 and SK-MEL-2 were purchased from the American Type Culture Collection (CRL- 1424 and HTB-68TM; ATCC).

    Techniques: Knockdown, Small Interfering RNA, MTT Assay, Staining, Control

    Fig. 4. Inhibition of Dock180 and Elmo1 changes cell cycles and apoptosis of G361 and SK-MEL-2 cells. (A) Cell distribution at G0/G1, S, and G2/M phases was analyzed at 48 hours of incubation time using flow cytometry after staining with propidium iodide (20 μg/ml). (B) The percentage of apoptotic cells after Annexin V-PE binding was analyzed at 48 hours of incubation time using a Muse cell analyzer. The quantitative data were shown as mean±standard deviations for three independent experiments. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.

    Journal: Annals of dermatology

    Article Title: Overexpression of Dock180 and Elmo1 in Melanoma is Associated with Cell Survival and Migration.

    doi: 10.5021/ad.23.023

    Figure Lengend Snippet: Fig. 4. Inhibition of Dock180 and Elmo1 changes cell cycles and apoptosis of G361 and SK-MEL-2 cells. (A) Cell distribution at G0/G1, S, and G2/M phases was analyzed at 48 hours of incubation time using flow cytometry after staining with propidium iodide (20 μg/ml). (B) The percentage of apoptotic cells after Annexin V-PE binding was analyzed at 48 hours of incubation time using a Muse cell analyzer. The quantitative data were shown as mean±standard deviations for three independent experiments. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.

    Article Snippet: The human melanoma cell lines G361 and SK-MEL-2 were purchased from the American Type Culture Collection (CRL- 1424 and HTB-68TM; ATCC).

    Techniques: Inhibition, Incubation, Flow Cytometry, Staining, Binding Assay, Control

    Fig. 5. Inhibition of migration and colony formation in G361 and SK-MEL-2 cells by knockdown of Dock180 and Elmo1. (A) Transfec- tion with Dock180- or Elmo1-specific small interfering RNA (siRNA) induced the inhibition of melanoma cell migration. At 24 hours post-transfection, the cells were grown to near confluence, and then wounded by dragging a 20 µl pipette tip through the monolayer. Cell migration images were captured soon after the wound was introduced (0 hour) and at a designated time (48 hours after wounding) under a microscope. (B) In 2 weeks after transfection with Dock180- or Elmo1-specific siRNA, colony formation of the G361 cells was suppressed. Immunoblot analysis of Dock180, Elmo1, Rac1 and phosphorylation of ERK and AKT in G361 and SK-MEL-2 cells treated with Dock180- or Elmo1-specific siRNA. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.

    Journal: Annals of dermatology

    Article Title: Overexpression of Dock180 and Elmo1 in Melanoma is Associated with Cell Survival and Migration.

    doi: 10.5021/ad.23.023

    Figure Lengend Snippet: Fig. 5. Inhibition of migration and colony formation in G361 and SK-MEL-2 cells by knockdown of Dock180 and Elmo1. (A) Transfec- tion with Dock180- or Elmo1-specific small interfering RNA (siRNA) induced the inhibition of melanoma cell migration. At 24 hours post-transfection, the cells were grown to near confluence, and then wounded by dragging a 20 µl pipette tip through the monolayer. Cell migration images were captured soon after the wound was introduced (0 hour) and at a designated time (48 hours after wounding) under a microscope. (B) In 2 weeks after transfection with Dock180- or Elmo1-specific siRNA, colony formation of the G361 cells was suppressed. Immunoblot analysis of Dock180, Elmo1, Rac1 and phosphorylation of ERK and AKT in G361 and SK-MEL-2 cells treated with Dock180- or Elmo1-specific siRNA. si-Ctrl: siRNA control, si-Dock180: siRNA targeting Dock180, si-Elmo1: siRNA targeting Elmo1. *p<0.05 compared to untreated controls.

    Article Snippet: The human melanoma cell lines G361 and SK-MEL-2 were purchased from the American Type Culture Collection (CRL- 1424 and HTB-68TM; ATCC).

    Techniques: Inhibition, Migration, Knockdown, Small Interfering RNA, Transfection, Transferring, Microscopy, Western Blot, Phospho-proteomics, Control

    Fig. 4 Increase of WIPI1 protein enhances autophagic flux. a Immunoblot analysis of LC3B lipidation in U2OS cells after transfection with control plasmids (9E10) or plasmids encoding 9E10-tagged WIPI1. U2OS cells were transfected with the indicated amounts of plasmids for 48 h before protein extraction and immunoblotting against LC3B, 9E10-tagged WIPI1 or GAPDH, n = 3. Additional immunoblots provided in Supplementary Fig. 5a. b U2OS Cas9 control or U2OS WIPI1 KO cells were transfected with control plasmids (9E10) or plasmids encoding 9E10-tagged WIPI1 for 48 h, followed by treatment with bafilomycin A1 (BafA1) in fed conditions for 3 h. Immunoblotting was conducted against LC3B, 9E10 and tubulin (n = 6, mean ± SD, Two-way ANOVA with Tukey’s multiple comparisons test). WIPI1 deficiency control Taqman qPCR is presented in Supplementary Fig. 6b, and representative Western blots in Supplementary Fig. 6c. c U2OS cells stably expressing GFP-WIPI2 were transfected with control plasmids or plasmids encoding mCherry-tagged WIPI1 for 48 h. The numbers of GFP-WIPI2 puncta cells were assessed by fluorescence microscopy in transfected cells. Welch’s t test, mean ± SD, up to 1272 analysed cells from n = 4 in duplicates. d U2OS Cas9 control or U2-OS WIPI1-KO cells were seeded into 96-well glass bottom plates and transfected with siABL1/2, siDDR1 or nontargeting siRNA (siControl) for 48 h, followed by treatment with either DMEM/FBS (fed) or EBSS (starved) for 3 h. After fixation, cells were stained with DAPI and anti-WIPI2/AF488. By automated confocal LSM, 20 images per well were acquired and between 621 to 2563 single cells (from n = 3) subjected to automated CellProfiler-based image analysis (threshold-based puncta segmentation). For statistical analysis, a two-way ANOVA with Tukey’s multiple comparisons test was performed (mean ± SD). e G361 cells were transfected with plasmids encoding GFP or GFP-WIPI1 and were fed or starved for 3 h in the presence or absence of bafilomycin A1, followed by anti-WIPI2/AF546 immunofluorescence staining. Confocal LSM stacks were acquired, and the numbers of WIPI2 puncta-positive cells per acquired image (individual data points represent the result derived from each image) were counted (left panel: two-way ANOVA with Tukey’s post-hoc test, mean ± SD, up to 215 single cells from n = 3 for each condition). Indicative of the presence of overexpressed GFP-WIPI1 are elongated, perinuclear autophagic membranes found to colocalize with WIPI2 (right panel: Scale bar: 5 μm, extended image presentation in Supplementary Fig. 5b). Supplementary material is available (Supplementary Fig. 6d; Supplementary Data 1). P values: *p < 0.05; **p < 0.01; ***p < 0.001; ns not significant.

    Journal: Communications biology

    Article Title: The ABL-MYC axis controls WIPI1-enhanced autophagy in lifespan extension.

    doi: 10.1038/s42003-023-05236-9

    Figure Lengend Snippet: Fig. 4 Increase of WIPI1 protein enhances autophagic flux. a Immunoblot analysis of LC3B lipidation in U2OS cells after transfection with control plasmids (9E10) or plasmids encoding 9E10-tagged WIPI1. U2OS cells were transfected with the indicated amounts of plasmids for 48 h before protein extraction and immunoblotting against LC3B, 9E10-tagged WIPI1 or GAPDH, n = 3. Additional immunoblots provided in Supplementary Fig. 5a. b U2OS Cas9 control or U2OS WIPI1 KO cells were transfected with control plasmids (9E10) or plasmids encoding 9E10-tagged WIPI1 for 48 h, followed by treatment with bafilomycin A1 (BafA1) in fed conditions for 3 h. Immunoblotting was conducted against LC3B, 9E10 and tubulin (n = 6, mean ± SD, Two-way ANOVA with Tukey’s multiple comparisons test). WIPI1 deficiency control Taqman qPCR is presented in Supplementary Fig. 6b, and representative Western blots in Supplementary Fig. 6c. c U2OS cells stably expressing GFP-WIPI2 were transfected with control plasmids or plasmids encoding mCherry-tagged WIPI1 for 48 h. The numbers of GFP-WIPI2 puncta cells were assessed by fluorescence microscopy in transfected cells. Welch’s t test, mean ± SD, up to 1272 analysed cells from n = 4 in duplicates. d U2OS Cas9 control or U2-OS WIPI1-KO cells were seeded into 96-well glass bottom plates and transfected with siABL1/2, siDDR1 or nontargeting siRNA (siControl) for 48 h, followed by treatment with either DMEM/FBS (fed) or EBSS (starved) for 3 h. After fixation, cells were stained with DAPI and anti-WIPI2/AF488. By automated confocal LSM, 20 images per well were acquired and between 621 to 2563 single cells (from n = 3) subjected to automated CellProfiler-based image analysis (threshold-based puncta segmentation). For statistical analysis, a two-way ANOVA with Tukey’s multiple comparisons test was performed (mean ± SD). e G361 cells were transfected with plasmids encoding GFP or GFP-WIPI1 and were fed or starved for 3 h in the presence or absence of bafilomycin A1, followed by anti-WIPI2/AF546 immunofluorescence staining. Confocal LSM stacks were acquired, and the numbers of WIPI2 puncta-positive cells per acquired image (individual data points represent the result derived from each image) were counted (left panel: two-way ANOVA with Tukey’s post-hoc test, mean ± SD, up to 215 single cells from n = 3 for each condition). Indicative of the presence of overexpressed GFP-WIPI1 are elongated, perinuclear autophagic membranes found to colocalize with WIPI2 (right panel: Scale bar: 5 μm, extended image presentation in Supplementary Fig. 5b). Supplementary material is available (Supplementary Fig. 6d; Supplementary Data 1). P values: *p < 0.05; **p < 0.01; ***p < 0.001; ns not significant.

    Article Snippet: Human U2OS osteosarcoma cells (ATCC, HTB-96) or human G361 malignant melanoma cells (ATCC; CRL-1424) were cultured in Dulbecco’s modified Eagle medium (DMEM) GlutaMAX (Life Technologies, 31966)/10% fetal bovine serum (Life Technologies, 10270-106) supplemented with 100 U/ml penicillin/100mg/ml streptomycin (Life Technologies, 15140-122) at 37 °C and 5% CO2.

    Techniques: Western Blot, Transfection, Control, Protein Extraction, Stable Transfection, Expressing, Microscopy, Staining, Derivative Assay